Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Saloshnee Naidoo"'
Autor:
Lonji Kalombo, Yolandy Lemmer, Boitumelo Semete-Makokotlela, Bathabile Ramalapa, Patric Nkuna, Laetitia L.L.I.J. Booysen, Saloshnee Naidoo, Rose Hayeshi, Jan A. Verschoor, Hulda S. Swai
Publikováno v:
Nanomaterials, Vol 9, Iss 8, p 1167 (2019)
Aiming to improve the treatment outcomes of current daily tuberculosis (TB) chemotherapy over several months, we investigated whether nanoencapsulation of existing drugs would allow decreasing the treatment frequency to weekly, thereby ultimately imp
Externí odkaz:
https://doaj.org/article/e27f5f266d4b4e78ae6a9d20e2ee62a4
Autor:
Hulda Swai, Sara Liparoti, Philip W Labuschagne, Renata Adami, Ernesto Reverchon, Saloshnee Naidoo
Publikováno v:
The Journal of Supercritical Fluids. 95:106-117
Copyright: 2014 Elsevier. Only the abstract if provided. The fulltext version of the work is published in The Journal of Supercritical Fluids, vol. 95, pp 106-117 and is available from the publisher.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f17dd6de291205299b11ffd3c09c492
https://doi.org/10.1016/j.supflu.2014.08.004
https://doi.org/10.1016/j.supflu.2014.08.004
Autor:
Boitumelo Semete-Makokotlela, Patric Nkuna, Jan A. Verschoor, Laetitia Booysen, Rose Hayeshi, Bathabile Ramalapa, Lonji Kalombo, Hulda Swai, Saloshnee Naidoo, Yolandy Lemmer
Publikováno v:
Nanomaterials, Vol 9, Iss 8, p 1167 (2019)
Nanomaterials
Volume 9
Issue 8
Nanomaterials
Volume 9
Issue 8
Aiming to improve the treatment outcomes of current daily tuberculosis (TB) chemotherapy over several months, we investigated whether nanoencapsulation of existing drugs would allow decreasing the treatment frequency to weekly, thereby ultimately imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::602bf01bdb0317b2e7bd2a66d229a82b
https://doi.org/10.3390/nano9081167
https://doi.org/10.3390/nano9081167
Autor:
Saloshnee Naidoo, Yolandy Lemmer, Paul Kiprono Chelule, Rose Hayeshi, Bathabile Ramalapa, Laetitia Booysen, Boitumelo Semete, Hulda Swai, Lebogang Katata, Lonji Kalombo
Publikováno v:
Molecular Crystals and Liquid Crystals. 556:317-330
Current treatment of tuberculosis is inadequate due to lengthy treatment course and drug-related toxicity. To address these setbacks, we developed a nanotechnology drug delivery system that can be administered in a single dose that maintains an activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80e7281a4d8b645499b0adeabd80c0c9
https://doi.org/10.1080/15421406.2012.635531
https://doi.org/10.1080/15421406.2012.635531
Publikováno v:
Journal of Nanoparticle Research. 14
Efavirenz (EFV) is one of the first-line antiretroviral drugs recommended by the World Health Organisation for treating HIV. It is a hydrophobic drug that suffers from low aqueous solubility (4 μg/mL), which leads to a limited oral absorption and lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b9a112d9cef371060e9a4ba9fe70710
https://doi.org/10.1007/s11051-012-1247-0
https://doi.org/10.1007/s11051-012-1247-0